InsidersTradesSigma
Follow the Sotera Health Co share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Sotera Health Co has published 116 reports. Market capitalisation: €5.4bn. The latest transaction was filed on 19 August 2026 (Cession). Among the most active insiders: Petras Michael B. Jr.. The full history is accessible without an account.
116
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4bn
28 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sotera Health Co Buy (bullish), based on 9 analysts. Average price target: US$22.72.
54Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,155 of 29,064 companies
50.9
score / 100
Value41
Quality61
FCF yld2.8%
Earn yld1.4%
EV/EBITDA17.4x
ROE28%
Gross mgn55%
Net mgn6.7%
Debt/EBITDA5.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
Declarations116 total
294,515 shares@ US$18.5011Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-356962:0
850,000 shares@ US$18.5011Common StockSEC:0001193125-26-356962:1
150,000 shares@ US$18.8350.053% mcap29.2% of flowCommon Stock, $0.01 par value per shareSEC:0001193125-26-344757:0
150,000 shares@ US$18.910.053% mcap41.3% of flowCommonSEC144:0001949846-26-000475
11,316 shares@ US$17.980.0039% mcap32.3% of flowCommon Stock, $0.01 par value per shareSEC:0001193125-26-340288:0
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242237:0
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242188:0
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242231:0
19,102,952 shares@ US$15.1684.93% mcap25.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-26-010903:0
12,735,301 shares@ US$15.1683.29% mcap50.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-227029:0
19,102,952 shares@ US$15.1684.93% mcap25.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-26-010899:0
7,941 shares@ US$14.3450.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-140422:0
15,000,000 shares@ US$15.277.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-26-005532:0
15,000,000 shares@ US$15.277.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-26-005534:0
10,000,000 shares@ US$15.2714.1% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-100568:0
31,339 shares@ US$15.915.7% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-092231:0
7,941 shares@ US$15.9135.3% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-092210:0
6,046 shares@ US$15.9122.1% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-092207:0
3,729 shares@ US$15.911.4% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-092194:0
315,896 shares@ US$16.4564.2% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-25-314343:0
9,720,000 shares@ US$16.335.7% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-25-310142:0
6,480,000 shares@ US$16.3311.3% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-25-310122:0
9,720,000 shares@ US$16.335.7% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-25-310134:0
18,000,000 shares@ US$15.65111.4% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-25-017526:0
18,000,000 shares@ US$15.65111.4% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-25-017529:0
25 of 116 declarations
关于 Sotera Health Co
Sotera Health Co (Nasdaq: SHC) 是一家总部位于美国的医疗保健服务公司，专注于为医疗设备、制药和更广泛的医疗保健客户提供关键任务的灭菌、实验室检测和咨询服务。该公司在美国纳斯达克市场上市，其公司总部位于俄亥俄州布罗德维尤高地。实际上，Sotera Health 在医疗保健供应链中占据着关键位置：它帮助客户满足严格的安全、质量和监管要求，这些要求在内部难以复制。([investors.soterahealth.com](https://investors.soterahealth.com/static-files/50a6a4b6-cb76-4bff-861d-0c21a4875633?utm_source=openai)) 该集团通过三个主要平台运营。Sterigenics 提供工业灭菌解决方案，包括伽马射线照射、电子束和环氧乙烷服务，支持医疗设备和其他医疗保健产品的灭菌。Nordion 是钴-60（用于伽马灭菌的同位素）的关键供应商，使该公司在灭菌生态系统中扮演着战略上重要的角色。Nelson Labs 提供微生物检测、验证和咨询服务，帮助制造商验证产品并证明合规性。这些业务共同创造了一个集成的产品，涵盖了产能、原材料和实验室专业知识。([investors.soterahealth.com](https://investors.soterahealth.com/news-releases/news-release-details/sotera-health-reports-fourth-quarter-and-full-year-2024-results/?utm_source=openai)) 从行业角度来看，Sotera Health 受益于相对防御性的业务模式。需求受到医疗保健消费、经常性客户关系以及灭菌和检测服务至关重要且受到严格监管的事实的支持。进入壁垒很高，因为它们依赖于专业资产、技术专长、客户资质和监管批准。该公司强调其作为“关键任务端到端灭菌解决方案”和实验室服务提供商的角色，这突显了其市场地位的持久性。([investors.soterahealth.com](https://investors.soterahealth.com/news-releases/news-release-details/sotera-health-chairman-and-ceo-presents-43rd-annual-jp-morgan?utm_source=openai)) Sotera Health 的国际化程度超出了其俄亥俄州总部所暗示的范围。其客户遍布北美、欧洲和其他医疗保健制造中心，因此其业务与全球医疗设备和制药供应链紧密相连。这种地域分布很重要，因为灭菌和检测能力通常需要靠近制造基地，而采购和合规需求是全球性的。([investors.soterahealth.com](https://investors.soterahealth.com/static-files/50a6a4b6-cb76-4bff-861d-0c21a4875633?utm_source=openai)) 关于最新进展，该公司报告了2024财年业绩，突显了又一年的营收增长，并提供了2025年指引。2025年2月，管理层表示2024年营收预计约为1.1 billion美元，同比增长约5%，公司随后报告2024年营收为1.100 billion美元。最近，2026年2月，Sotera Health 宣布其董事会成员从11名增加到12名，并任命了一名新董事会成员，这是一项显著的公司治理更新。对于投资者而言，主要主题仍然是稳定的营收增长、运营优化以及对与商业模式相关的法律和监管事项的持续监控。([investors.soterahealth.com](https://investors.soterahealth.com/news-releases/news-release-details/sotera-health-chairman-and-ceo-presents-43rd-annual-jp-morgan?utm_source=openai))
